Private · Company · Aksjeselskap
Immunopharma AS
↳ Brreg · companies
MoneyNOK
Group revenue
kr 63.9M
Group net
kr 51M
Tenders won
0
Rolled up across the parent + 5 subsidiaries — Nordic Healthy Living AS alone is kr 36.1M.
rollup estimate · filed konsernregnskap not yet in Intelligo
Regnskapsregisteret · rollup across ownership edges (estimate)
Group financialsNOK
- Revenue
- Net profit
| FY22 | FY23 | FY24 | FY25 | |
|---|---|---|---|---|
| Revenue | 21.1M | 14.1M | 12.2M | 18M |
| Net profit | — | — | — | -4.51M |
Regnskapsregisteret · company_revenue
Key figuresBrønnøysund
FY22FY23FY24FY25TREND
Revenue21M14M12M18M
Operating result-7M-13M-39M-20M
Net result———-5M
Regnskapsregisteret · company_revenue
From the FY2025 accounts
FILEDAccounts filed for FY2025.
AUDITAudited by FORVIS MAZARS AS.
GROUPFiles as a parent with 5 subsidiaries.
BALANCEEquity kr 204.5M.
Regnskapsregisteret + Brreg roles · the annual-report PDF is a paid Brønnøysund document, so these are the filed facts, not extracted prose